Arlocabtagene Autoleucel

2 trials 2 recruiting

Filter these 2 trials by condition, phase, country and more.

Open in Search →

2 Registered trials

2 Recruiting

0 Completed trials

1 Sponsors

17 Countries

Phase III

Phase II/III

Phase III: 1 Phase II/III: 1

Sponsors using this IMP

Celgene Corp. 2

All trials

2 total

A Phase 3 Study of a GPRC5D-directed CAR T Cell Therapy in Participants with Relapsed or Refractory Multiple Myeloma and Exposed to Lenalido… Recruiting

2024-515279-37-00 Phase III 17 countries Celgene Corp.
Long-Term Follow-up Protocol for Subjects Treated with Gene-Modified T cells. Recruiting

2023-504201-36-00 Phase II/III 17 countries Celgene Corp.

Showing 1–2 of 2 trials

← All drugs A–Z